Close
Research
Top discoveries
King and Queen meet UCL cancer specialists at UCLH
Their Majesties, King Charles and Queen Camilla met UCL clinical researchers developing new cancer treatments, along with cancer patients receiving care.
Perimenopausal physical activity and the risk of dementia
Physical activity during the perimenopausal period may be crucial in mitigating the risk of cognitive decline in later life.
New trial to find best way to screen men for prostate cancer
Methods of screening men for prostate cancer are set to be trialled in a bid to save thousands of lives in the UK each year. (Evening Standard)
Injury risk varies in menstrual cycle
New research monitoring a Women's Super League club for three years suggests players are more likely to get injured at certain points of their menstrual cycle.
Chronic kidney disease progresses faster in hot countries
Chronic kidney disease patients living in the hottest countries experienced an additional 8% drop in kidney function each year compared to those living in temperate climates, finds a new study.
Our research departments
Ageing, Rheumatology & Regenerative Medicine
(Division of Medicine)
Biomaterials and Tissue Engineering
(Eastman Dental Institute)
Cancer Biology
(Cancer Institute)
Clinical Trials
(Cancer Institute)
Dental Clinical Research
(Eastman Dental Institute)
Haematology
(Cancer Institute)
Infection
(Division of Infection & Immunity)
Imaging
(Division of Medicine)
Immunity and Transplantation
(Division of Infection & Immunity)
Inflammation & Rare Diseases
(Division of Medicine)
Liver and Digestive Health
(Division of Medicine)
Medical Education
(UCL Medical School)
Microbial Diseases
(Eastman Dental Institute)
Neuroscience
(Division of Medicine)
Oncology
(Cancer Institute)
Orthopaedics and Musculoskeletal Science
(Division of Surgery & Interventional Science)
Pathology
(Cancer Institute)
Renal Medicine
(Division of Medicine)
Respiratory Medicine
(Division of Medicine)
Surgical Biotechnology
(Division of Surgery & Interventional Science)
Targeted Intervention
(Division of Surgery & Interventional Science)
Research by Division
Podcast: What it takes to rise to the top as a woman in medicine
Medical Women Talking is a new series of interviews with a range of inspiring women doctors from different specialties and backgrounds who've had successful careers in medicine. They explore topics such as overcoming sexism, becoming a leader, and how to make the NHS more accommodating. Hosted by Professor Dame Jane Dacre.
Advances in cancer treatment
To mark World Cancer Day 2024, we are looking at how University College London is taking new and different approaches to tackling cancer.
Professor Jayant Vaidya explains how we're transforming the treatment of breast cancer treatment from weeks of radiotherapy to a one-off targeted therapy.
Case study: Single-dose radiotherapy transforms breast cancer patient care
UCL clinicians have pioneered a single-shot targeted radiotherapy for breast cancer to be delivered in the same operation as tumour surgery. This removes the need for follow-ups and reduces debilitating side-effects. The single-shot targeted intraoperative radiotherapy (TARGIT-IORT) was developed by a team led by Professor Jayant Vaidya at UCL's Division of Surgery and Interventional Science.
Research services
Surgical Interventional Group (Clinical Trials)
SIG provides infrastructure for studies led by surgeons and interventionists within any anatomical site. It has history of managing large-scale multi-centre, multinational randomised controlled clinical trials in solid tumours.
Tissue Access for Patient Benefit
TAPb facilitates the access, storage, use and transfer of human organs, cells, and tissue between clinical centres within UCL and a range of institutions to help researchers access the materials they need.